BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 18228425)

  • 1. The chick chorioallantoic membrane as an in vivo angiogenesis model.
    Ponce ML; Kleinmann HK
    Curr Protoc Cell Biol; 2003 May; Chapter 19():Unit 19.5. PubMed ID: 18228425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chick embryo chorioallantoic membrane as a useful tool to study angiogenesis.
    Ribatti D
    Int Rev Cell Mol Biol; 2008; 270():181-224. PubMed ID: 19081537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of collateral vessels: A new paradigm in CAM angiogenesis model.
    Gatne DP; Mungekar S; Addepalli V; Mohanraj K; Ghone SA; Rege NN
    Microvasc Res; 2016 Jan; 103():11-3. PubMed ID: 26390964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
    Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
    Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Choline promotes angiogenesis in chick embryo chorioallantoic membrane].
    Wang H; Zeng XZ; Cui WY; Duan L
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2013 May; 29(3):229-31. PubMed ID: 23940955
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The chick embryo chorioallantoic membrane as a model system for the study of tumor angiogenesis, invasion and development of anti-angiogenic agents.
    Tufan AC; Satiroglu-Tufan NL
    Curr Cancer Drug Targets; 2005 Jun; 5(4):249-66. PubMed ID: 15975046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two new applications in the study of angiogenesis the CAM assay: Acellular scaffolds and organoids.
    Ribatti D
    Microvasc Res; 2022 Mar; 140():104304. PubMed ID: 34906560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo.
    Ribatti D; Nico B; Vacca A; Roncali L; Burri PH; Djonov V
    Anat Rec; 2001 Dec; 264(4):317-24. PubMed ID: 11745087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo angiogenic activity of erythropoietin.
    Ribatti D
    Methods Mol Biol; 2013; 982():227-35. PubMed ID: 23456873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis.
    Ribatti D; Vacca A; Roncali L; Dammacco F
    Int J Dev Biol; 1996 Dec; 40(6):1189-97. PubMed ID: 9032025
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of angiogenic properties of biomaterials using the chicken embryo chorioallantoic membrane assay.
    Azzarello J; Ihnat MA; Kropp BP; Warnke LA; Lin HK
    Biomed Mater; 2007 Jun; 2(2):55-61. PubMed ID: 18458436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In ovo leptin administration inhibits chorioallantoic membrane angiogenesis in female chicken embryos through the STAT3-mediated vascular endothelial growth factor (VEGF) pathway.
    Su L; Rao K; Guo F; Li X; Ahmed AA; Ni Y; Grossmann R; Zhao R
    Domest Anim Endocrinol; 2012 Jul; 43(1):26-36. PubMed ID: 22417645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tryptase and chymase are angiogenic in vivo in the chorioallantoic membrane assay.
    Ribatti D; Ranieri G; Nico B; Benagiano V; Crivellato E
    Int J Dev Biol; 2011; 55(1):99-102. PubMed ID: 21425085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of the chick embryo CAM assay in the study of angiogenic activiy of biomaterials.
    Ribatti D; Annese T; Tamma R
    Microvasc Res; 2020 Sep; 131():104026. PubMed ID: 32505611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nerve growth factor (NGF) promotes angiogenesis in the quail chorioallantoic membrane.
    Lazarovici P; Gazit A; Staniszewska I; Marcinkiewicz C; Lelkes PI
    Endothelium; 2006; 13(1):51-9. PubMed ID: 16885067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Experimental approaches to study in vivo angiogenesis].
    Kilarski W; Bikfalvi A
    Bull Cancer; 2007 Jul; 94 Spec No():S166-9. PubMed ID: 17846001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel angiogenesis model for screening anti-angiogenic compounds: the chorioallantoic membrane/feather bud assay.
    Chen H; Wang CS; Li M; Sanchez E; Li J; Berenson A; Wirtschafter E; Wang J; Shen J; Li Z; Bonavida B; Berenson JR
    Int J Oncol; 2010 Jul; 37(1):71-9. PubMed ID: 20514398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluronic F127 as a drug vehicle used in chick embryo chorioallantoic membrane shell-less model.
    Shi T; Li Z; Zhang Q; Zheng D; Li Z
    Pak J Pharm Sci; 2015 Nov; 28(6):1997-9. PubMed ID: 26639476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examination of the role of galectins during in vivo angiogenesis using the chick chorioallantoic membrane assay.
    Kleibeuker EA; Schulkens IA; Castricum KC; Griffioen AW; Thijssen VL
    Methods Mol Biol; 2015; 1207():305-15. PubMed ID: 25253149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental study of Solanum nigrum on inhibiting angiogenesis in chick chorioallantoic membrane].
    Xu Y; Pan RL; Chang Q; Qin M; Liu Y; Tang JT
    Zhongguo Zhong Yao Za Zhi; 2008 Mar; 33(5):549-52. PubMed ID: 18536381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.